Creatineobservational1981

[Affinity modification of creatine kinase from rabbit skeletal muscles using gamma-(p-azidoanilide)-ATP].

Biokhimiia (Moscow, Russia)

confidence

Key findings

gamma-(p-azidoanilide)-ATP is an affinity label for the active site of creatine kinase; inactivation and covalent binding observed.

View source on PubMed (PMID 7018594) ↗

Sample size
Not reported
Population
Rabbit skeletal muscle creatine kinase (in vitro enzyme study)
Dosing
gamma-(p-azidoanilide)-[14C]-ATP with UV irradiation; MgADP, MgATP, and creatine as modifiers
Duration
Not reported
Route
In vitro
Blinding
not_reported
Controls
none
Drug class
nootropic
Full abstract

Ultraviolet irradiation of creatine kinase (adenosine 5'-triphosphate: creatine-N-phosphotransferase, EC 2.7.3.2) in the presence of gamma-(p-azidoanilide)-[14C]-ATP results in a complete enzyme inactivation and covalent binding of two moles of analog per mole of enzyme. MgADP strongly protects the enzyme against inactivation. However, in the presence of MgADP the covalent binding of 0.9 moles of analog per mole of enzyme occurs without the enzyme inactivation. The rate of enzyme inactivation and covalent modification decreases in the presence of MgATP and creatine. These results indicate that gamma-(p-azidoanilide)-ATP is an affinity label for the active site of creatine kinase.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.